Saiers Capital’s Fibrocell Science Inc. FCSC Stock Holding History

Saiers Capital’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,714	Closed	-$317K	–	184
2015 Q1	$319K	Hold	4,714	–	–	0.25%	76
2014 Q4	$183K	Hold	4,714	–	–	0.06%	163
2014 Q3	$205K	Hold	4,714	–	–	0.09%	101
2014 Q2	$282K	Hold	4,714	–	–	0.09%	132
2014 Q1	$370K	Hold	4,714	–	–	0.11%	96
2013 Q4	$287K	Hold	4,714	–	–	0.02%	172
2013 Q3	$310K	Hold	4,714	–	–	0.05%	196
2013 Q2	$433K	Buy	+4,714	New	+$390K	0.05%	162

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Saiers Capital's FCSC Position: Q2 2015 in Review

Saiers Capital sold out of Fibrocell Science Inc. (FCSC) in Q2 2015, closing a stake of 4,714 shares — an estimated $317K sold.

Saiers Capital first reported a position in FCSC in Q2 2013 and held it in 8 quarters. The position peaked at $433K in Q2 2013. 55 funds tracked by Wall St. Rank hold FCSC as of Q2 2015.

Saiers Capital reported no remaining Fibrocell Science Inc. position as of Q2 2015 after selling out during the quarter.
Saiers Capital sold 4,714 Fibrocell Science Inc. shares in Q2 2015, an estimated $317K.
Saiers Capital first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 8 quarters.
Saiers Capital's Fibrocell Science Inc. position peaked at $433K in Q2 2013.
55 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2015.

Based on Saiers Capital's 13F filing for Q2 2015, filed 11 Aug 2015.